Optimizing Freeze Thaw Processes for Cell and Gene Therapy Commercialization

Register Free: https://www.biopharminternational.com/bp_w/Cell_Gene

Event Overview:

Cold Chain processes and operations are playing an increasing role in the development and commercialization of novel bioprocess therapeutics. Numerous cell and gene therapy workflows rely on the ability of the process to be halted and re-established via freezing and thawing of intermediate and final product formulations. In this webcast learn about,

• Facilities and infrastructure to design and deploy optimized freeze thaw workflows
• Single-use-systems protect the integrity, efficacy, and purity of your product
• Capabilities to support your achieving critical clinical development and commercialization objectives.

Key Learning Objectives:

• Understand process and tool decisions that help overcome future complexity and uncertainty
• See how to address freeze thaw manufacturing capacity and infrastructure challenges
• Discover working in partnership with a well-resourced freeze thaw ecosystem center

Who Should Attend:

• MS&T Engineers/Scientists (Manufacturing Science & Technology)
• Process Development Engineer/Scientists
• Associate/Senior Director of Process Sciences and Manufacturing

Speakers

Ross Acucena
Applications Director, Life Sciences
Entegris, Inc.

Ross has 20 years of experience in pharma and biopharma as a process engineer and manufacturing leader. The last 14 years working in Technical Marketing, Regulatory Consulting, Product Development, and Business Leadership at MilliporeSigma, GE Biopharma, and currently with Entegris. Ross’ work has focused on filtration applications and the successful implementation of single-use across bioprocess unit operations. He holds an Bsc. In Chemical Engineering and MBA both from U-mass Lowell.

Register Free: https://www.biopharminternational.com/bp_w/Cell_Gene